All Stories

  1. Gene transfer in hemophilia B: a big step forward

    Article • Bleeding Thrombosis and Vascular Biology, May 2023, PAGEPress Publications

    Dr Giancarlo Castaman

  2. Hemophilia B: Diagnosis and Management

    Article • January 2023, Springer Science + Business Media

    Dr Giancarlo Castaman

  3. Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications

    Article • Journal of Clinical Medicine, November 2022, MDPI AG

    Dr Giancarlo Castaman

  4. Current and emerging biologics for the treatment of hemophilia

    Article • Expert Opinion on Biological Therapy, April 2019, Taylor & Francis

    Dr Giancarlo Castaman

  5. Advances in diagnosis of von Willebrand disease

    Article • Expert Opinion on Orphan Drugs, April 2019, Taylor & Francis

    Dr Giancarlo Castaman

  6. An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study

    Article • Journal of Thrombosis and Haemostasis, July 2018, Wiley

    Dr Imre Bodó, Dr Giancarlo Castaman

  7. The benefits of prophylaxis in patients with hemophilia B

    Article • Expert Review of Hematology, July 2018, Taylor & Francis

    Dr Giancarlo Castaman

  8. Management of thrombocytopenia in cancer

    Article • Thrombosis Research, April 2018, Elsevier

    Dr Giancarlo Castaman

  9. Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population

    Article • Haemophilia, December 2017, Wiley

    Professor Alfonso Iorio, ANTONIO COPPOLA, Dr Giancarlo Castaman

  10. Haematological Care of the Haemophilic Patient

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  11. Laboratory Aspects

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  12. Pathogenesis of the Haemophilic Arthropathy

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman, Daniela Melchiorre

  13. Pharmacokinetic Approach to the Treatment of Haemophilia

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  14. Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

    Article • Haemophilia, February 2017, Wiley

    Dr Giancarlo Castaman, Professor Alfonso Iorio

  15. Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A

    Article • Therapeutics and Clinical Risk Management, June 2016, Dove Medical Press

    Dr Giancarlo Castaman

  16. Emerging Issues in Diagnosis, Biology, and Inhibitor Risk in Mild Hemophilia A

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Giancarlo Castaman

  17. Type 2B von Willebrand Disease

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Giancarlo Castaman

  18. How I treat type 2 variant forms of von Willebrand disease

    Article • Blood, February 2015, American Society of Hematology

    Dr Giancarlo Castaman

  19. 2B or not 2B: when VWF is not a good platelet friend

    Article • Blood, October 2013, American Society of Hematology

    Dr Giancarlo Castaman

  20. New development in von Willebrand disease

    Article • Current Opinion in Hematology, September 2013, Wolters Kluwer Health

    Dr Giancarlo Castaman

  21. How I treat von Willebrand disease

    Article • Blood, August 2009, American Society of Hematology

    Dr Giancarlo Castaman

  22. Desmopressin for the treatment of haemophilia

    Article • Haemophilia, December 2007, Wiley

    Dr Giancarlo Castaman

  23. Treatment of von Willebrand disease

    Article • Seminars in Hematology, January 2005, Elsevier

    Dr Giancarlo Castaman

  24. Current Management of von Willebrand??s Disease

    Article • Drugs, October 1995, Springer Science + Business Media

    Dr Giancarlo Castaman

  25. Acquired transitory von Willebrand syndrome with ciprofloxacin

    Article • The Lancet, February 1994, Elsevier

    Dr Giancarlo Castaman